読み込み中
NASDAQHealthcareMedical - Specialties
最新データ
$8.63
+$0.07 · +0.82%
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
前日終値
$8.63
+$0.07 · +0.82%
日中の時刻はETです。市場データは遅延する場合があります。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日中レンジ
現在 $8.63
52週レンジ
現在 $8.63
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
56
まちまち
リスク
54
やや高いリスク
モメンタム
36
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日中レンジ
現在 $8.63
52週レンジ
現在 $8.63
| 指標（USD） | 2025年度 |
|---|---|
| 売上高 | 3204.1万 USD |
| 売上原価 | 606.6万 USD |
| 粗利益 | 2597.5万 USD |
| 研究開発 | 651.52万 USD |
| 販売・一般管理 | 6582.77万 USD |
| 営業費用 | 7234.29万 USD |
| 支払利息 | 96.74万 USD |
| 減価償却費と償却費 | 15.17万 USD |
| 営業利益 | −4636.79万 USD |
| 純利益 | −4649.82万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$25.00
上昇余地（189.69%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI356.9万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM172.36万0.00%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF129.28万0.00%954億 USD0.05%$235+0.80%
Schwab U.S. Small-Cap ETFSCHA45.26万0.00%218.24億 USD0.03%$32.79+0.40%
iShares Russell 2000 Growth ETFIWO45.19万0.00%139.17億 USD0.24%$356.78+0.94%
iShares Micro-Cap ETFIWC25.93万0.02%13.17億 USD0.60%$183+0.11%
Vanguard Russell 2000 ETFVTWO13.26万0.00%180億 USD0.06%$112.66+0.50%
Global X - Russell 2000 ETFRSSL4万—14.19億 USD0.08%$109.09+0.21%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAiShares Russell 2000 Growth ETFIWOiShares Micro-Cap ETFIWCVanguard Russell 2000 ETFVTWOGlobal X - Russell 2000 ETFRSSLAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
